Clinical Trials Browser

Terminated × toripalimab × Gastrointestinal × Clear all

NCT05427396 2025-12-03

A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors

Phase 1 Terminated

GastrointestinalGynecologic

Esophageal Squamous Cell Carcinoma, Uterine Cervical Neoplasms, Liver Neoplasms

NCT05657418 2025-06-06

A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced Pancreatic Cancer

Phase 1 Terminated

Gastrointestinal

Advanced Pancreatic Cancer

NCT04709380 2025-02-26

Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT

Phase 3 Terminated

Gastrointestinal

Radiotherapy

NCT04804696 2025-02-21

Toripalimab with Paclitaxel and Cisplatin As Neoadjuvant Treatment for Esophageal Squamous Cell Carcinoma

Phase 2 Terminated

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03867370 2023-11-29

Toripalimab in Combination With Lenvatinib as Neoadjuvant Therapy in Resectable Hepatocellular Carcinoma

Phase 1/2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular